542
Views
10
CrossRef citations to date
0
Altmetric
Review

Long-term pharmacotherapy of obesity in patients that have undergone bariatric surgery: pharmacological prevention and management of body weight regain

, , , , &
Pages 939-947 | Received 12 Dec 2018, Accepted 13 Feb 2019, Published online: 18 Mar 2019

References

  • World Health Organization. [ Cited November 2018]. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/
  • Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363:2211–2219.
  • Shukla AP, He D, Saunders KH, et al. Current concepts in management of weight regain following bariatric surgery. Expert Rev Endocrinol Metab. 2018 Mar;13(2):67–76. Epub 2018
  • Lauti M, Lemanu D, Zeng ISL, et al. Definition determines weight regain outcomes after sleeve gastrectomy. Surg Obes Relat Dis. 2017 Jul;13(7):1123–1129.
  • Busetto L, Dicker D, Azran C, et al. Practical recommendations of the obesity management task force of the European association for the study of obesity for the post-bariatric surgery medical management. Obes Facts. 2017;106:597–632. Epub 2017.
  • Cooper TC, Simmons EB, Webb K, et al. Trends in weight regain following Roux-en-Y gastric bypass (RYGB) bariatric surgery. Obes Surg. 2015;25(8):1474–1481.
  • Kushner RF, Sorensen KW. Curr Obes Rep. 2015 Jun; 4(2):198–206. doi:10.1007/s13679-015-0146-y.
  • Christou NV, Look D, MacLean L. Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years. Ann Surg. 2006 November;244(5):734–740.
  • Melby CL, Paris HL, Foright RM, et al. Attenuating the biologic drive for weight regain following weight loss: must what goes down always go back up? Nutrients. 2017 May 6;9(5):E468.
  • Mariani LM, Fusco A, Turriziani M, et al. Transient increase of plasma ghrelin after laparoscopic adjustable gastric banding in morbid obesity. Horm Metab Res. 2005;37:242–245.
  • Bohdjalian A, Langer FB, Shakeri-Leidenmuhler S, et al. Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg. 2010;20(5):535–540.
  • Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623–1630.
  • Meguid MM, Glade MJ, Middleton FA. Weight regain after rouxen-Y: a significant 20 % complication related to PYY. Nutrition. 2008;24:832–842.
  • de Jonge L, Bray GA, Smith SR, et al. Effect of diet composition and weight loss on resting energy expenditure in the POUNDS LOST study. Obesity (Silver Spring). 2012 Dec;20(12):2384–2389. Epub 2012.
  • Liu G, Liang L, Bray GA, et al. Thyroid hormones and changes in body weight and metabolic parameters in response to weight loss diets: the POUNDS LOST trial. Int J Obes (Lond). 2017 Jun;41(6):878–886. Epub 2017.
  • Lopes Gomes D, de Almeida Oliveira D, Dutra ES, et al. Resting energy expenditure and body composition of women with weight regain 24 months after bariatric surgery. Obes Surg. 2016 Jul;26(7):1443–1447.
  • Zakrzewska KE, Cusin I, Sainsbury A, et al. Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance. Diabetes. 1997;46(4):717–719.
  • Woods C, Tomlinson JW. The dehydrogenase hypothesis. Adv Exp Med Biol. 2015;872:353–380.
  • Rusch MD, Andris D. Maladaptive eating patterns after weight loss surgery. Nutr Clin Pract. 2007;22:41–49.
  • Cook CM, Edwards C. Success habits of long-term gastric bypass patients. Obes Surg. 1999;9:80–82.
  • Kalarchian MA, Marcus MD, Wilson GT, et al. Binge eating among gastric bypass patients at long-term follow-up. Obes Surg. 2002 Apr;12(2):270–275.
  • Pizato N, Botelho PB, Vss G, et al. Effect of grazing behavior on weight regain post-bariatric surgery: a systematic review. Nutrients. 2017;9(12):1322.
  • King WC, Chen JY, Mitchell JE, et al. Prevalence of alcohol use disorders before and after bariatric surgery. JAMA. 2012 Jun 20;307(23):2516–2525.
  • Lins Bastos EC, Gusmão Barbosa EMW, Moreira Silva Soriano G, et al. Determinants of weight regain after bariatric surgery. ABCD Arq Bras Cir Dig. 2013;26(Suplemento 1):26–32.
  • Thomas DD, Anderson WA, Apovian CM, et al. Weight recidivism after roux-en-y gastric bypass surgery: an 11-year experience in a multiethnic medical center. Obesity (Silver Spring). 2018 Nov 13. DOI:10.1002/oby.22360.
  • Stanford FC, Alfaris N, Gomez G, et al. The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center study. Surg Obes Relat Dis. 2017 March; 13(3):491–500.
  • Pilitsi E, Farr OM, Polyzos SA, et al. Pharmacotherapy of obesity: available medications and drugs under investigation. Metabolism. 2018 Nov 1:pii: S0026-0495(18)30228–2 Epub ahead of print. doi:10.1016/j.metabol.2018.10.010.
  • Schwartz J, Chaudhry UI, Suzo A, et al. Pharmacotherapy in conjunction with a diet and exercise program for the treatment of weight recidivism or weight loss plateau post-bariatric surgery: a retrospective review. Obes Surg. 2016 Feb; 26(2):452–458.
  • Hanipah ZN, Nasr EC, Bucak E. Efficacy of adjuvant weight loss medication after bariatric surgery. Surg Obes Rel Dis. 2018;14(1):93–98.
  • Pajecki D, Halpern A, Cercato C, et al. Short-term use of liraglutide in the management of patients with weight regain after bariatric surgery.Rev. Col Bras Cir. 2013 May-Jun;40(3):191–195.
  • Rye P, Modi R, Cawsey S, et al. Efficacy of high-dose liraglutide as an adjunct for weight loss in patients with prior bariatric surgery. Obes Surg. 2018 Nov;28(11):3553–3558.
  • Gorgojo-Martínez JJ, Feo-Ortega G, Serrano-Moreno C. Effectiveness and tolerability of liraglutide in patients with type 2 diabetes mellitus and obesity after bariatric surgery. Surg Obes Relat Dis. 2016 Dec;12(10):1856–1863. Epub 2016.
  • Zilberstein B, Pajecki D, Garcia de Brito AC, et al. Topiramate after adjustable gastric banding in patients with binge eating and difficulty losing weight. Obes Surg. 2004 Jun-Jul;14(6):802–805.
  • New York University School of Medicine. Novo Nordisk A/S. clinical efficacy and safety of using 3.0mg liraglutide to treat weight regain after roux-en-Y gastric bypass surgery. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US); 2000. [cited 2019 Feb 13]. Available From: https://clinicaltrials.gov/ct2/show/NCT03048578:NLMIdentifier:NCT03048578.
  • University College, London. Evaluation of liraglutide 3.0mg in patients with poor weight-loss and a suboptimal glucagon-like peptide-1 response (BARIOPTIMISE). ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US); 2000. [cited 2019 Feb 13]. Available From: https://clinicaltrials.gov/ct2/show/NCT03341429:NLMIdentifier:NCT03341429.
  • Takeda. EEfficacy of naltrexone HCl/Bupropion HCl extended release versus placebo for treatment of weight regain in participants post bariatric surgery. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US); 2000. [cited 2019 Feb 13]. Available From: https://clinicaltrials.gov/ct2/show/NCT02616315:NLMIdentifier:NCT02616315.
  • Camilleri M, Acosta A. Combination therapies for obesity. Metab Syndr Relat Disord. 2018 Oct;16(8):390–394. Epub 2018.
  • Oliverira Magro D, Geloneze B. Delfini R Long-term weight regain after gastric bypass: A 5-year prospective study. Obes Surg. 2008;18:648–651.
  • Karmali S, Brar B, Shi X. Weight recidivism post-bariatric surgery: A systematic review. Obes Surg. 2013;23:1922–1933.
  • Monaco-Ferreira DV, Leandro-Mehri VA. Weight regain 10 years after roux-en-Y gastric bypass. Obes Surg. 2017 May;27(5):1137–1144.
  • Busetto L, Dicker D, Azran C, et al. Obesity management task force of the European association for the study of obesity released “practical recommendations for the post-bariatric surgery medical management. Obes Surg. 2018 Jul; 28(7):2117–2121.
  • Froylich D, Abramovich-Segal T, PascalI G, et al. Long-term (over 10 years) retrospective follow-up of laparoscopic adjustable gastric banding. Obes Surg. 2018 Apr;28(4):976–980.
  • Stanford FC. Controversial issues: A practical guide to the use of weight loss medications after bariatric surgery for weight regain or inadequate weight loss. Surg Obesity Related Dis. 2018 Oct 30. pii: S1550-7289(18)30343-5. doi: 10.1016/j.soard.2018.10.020. [Epub ahead of print]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.